Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514959 | SCV000610453 | likely benign | not provided | 2017-05-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000615064 | SCV000732452 | benign | not specified | 2017-07-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001079664 | SCV000764288 | benign | Hereditary spastic paraplegia 11 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001848881 | SCV002105688 | likely benign | Hereditary spastic paraplegia | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002467846 | SCV002762906 | likely benign | Amyotrophic lateral sclerosis type 5 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002467847 | SCV002762907 | likely benign | Charcot-Marie-Tooth disease axonal type 2X | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV001079664 | SCV002762908 | likely benign | Hereditary spastic paraplegia 11 | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics | RCV000615064 | SCV005622281 | benign | not specified | 2024-04-10 | criteria provided, single submitter | clinical testing |